VRAYLAR® – A New Treatment Option for Schizophrenia & Bipolar I Disorder
Drug Review: Volume 23, Issue 5 (PDF) Schizophrenia is a mental disorder characterized by a range of symptoms including psychosis (hallucinations, delusions, and hyperactivity), reduced motivation, and withdrawal from social settings. It is estimated that almost 1% of Canadians suffer from schizophrenia. Bipolar I disorder is another mental disorder characterized by significant fluctuations in mood. It […]